{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T16:51:43Z","timestamp":1781628703513,"version":"3.54.5"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,28]],"date-time":"2025-12-28T00:00:00Z","timestamp":1766880000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"vor","delay-in-days":33,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Guangdong Provincial Medical Science and Technology Research Fund Project","award":["A2021237"],"award-info":[{"award-number":["A2021237"]}]},{"name":"Zhuhai Social Development Science and Technology Plan Project","award":["2220004000250"],"award-info":[{"award-number":["2220004000250"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Hyperuricemia is closely associated with an increased risk of chronic kidney disease (CKD) and is frequently accompanied by abnormal fat distribution. However, the relationship between fat distribution and CKD prevalence in hyperuricemic populations remains unclear. This study investigates the association between the weight-adjusted waist index (WWI) and CKD among adults with hyperuricemia, using data from the National Health and Nutrition Examination Survey (NHANES).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Data from 5,330 hyperuricemic adults (2007\u20132018 NHANES) were analyzed. WWI was calculated by dividing waist circumference by the square root of body weight. CKD was defined by an estimated glomerular filtration rate (eGFR) falling below 60 mL\/min\/1.73\u00a0m\u00b2 or by albuminuria levels greater than 30\u00a0mg\/g. To evaluate the linkage between WWI and CKD, weighted multivariate logistic regression models and restricted cubic spline (RCS) analyses were utilized.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Individuals within the highest WWI quartile faced a 60% greater prevalence of CKD compared to the lowest quartile (OR\u2009=\u20091.60, 95% CI\u2009=\u20091.01\u20132.53,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.047). RCS analysis revealed a composite pattern. The curve demonstrates a U-shape when WWI is below 11.36\u00a0cm\/\u221akg, shifting to an inverted U-shape as WWI exceeds 11.36\u00a0cm\/\u221akg.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>A significant association was observed between WWI and CKD prevalence in hyperuricemic adults, characterized by a composite U-shaped and inverted U-shaped relationship. This indicates the potential existence of an optimal WWI range associated with a lower prevalence of CKD. Further studies are required to confirm these observations.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12889-025-26076-8","type":"journal-article","created":{"date-parts":[[2025,12,28]],"date-time":"2025-12-28T05:35:23Z","timestamp":1766900123000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["U- and inverted U-shaped link between weight-adjusted waist index and chronic kidney disease in hyperuricemic adults"],"prefix":"10.1186","volume":"26","author":[{"given":"Danxuan","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuping","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,28]]},"reference":[{"issue":"5","key":"26076_CR1","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.jare.2017.03.003","volume":"8","author":"R El Ridi","year":"2017","unstructured":"El Ridi R, Tallima H. Physiological functions and pathogenic potential of uric acid: A review. J Adv Res. 2017;8(5):487\u201393. https:\/\/doi.org\/10.1016\/j.jare.2017.03.003.","journal-title":"J Adv Res"},{"issue":"7","key":"26076_CR2","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/s41584-020-0441-1","volume":"16","author":"M Dehlin","year":"2020","unstructured":"Dehlin M, Jacobsson L, Roddy E. Global epidemiology of gout: prevalence, incidence, treatment patterns and risk factors. Nat Rev Rheumatol. 2020;16(7):380\u201390. https:\/\/doi.org\/10.1038\/s41584-020-0441-1.","journal-title":"Nat Rev Rheumatol"},{"issue":"12","key":"26076_CR3","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1093\/rheumatology\/kez196","volume":"58","author":"G Singh","year":"2019","unstructured":"Singh G, Lingala B, Mithal A. Gout and hyperuricaemia in the USA: prevalence and trends. Rheumatology (Oxford). 2019;58(12):2177\u201380. https:\/\/doi.org\/10.1093\/rheumatology\/kez196.","journal-title":"Rheumatology (Oxford)"},{"issue":"9","key":"26076_CR4","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1093\/ndt\/gft029","volume":"28","author":"RJ Johnson","year":"2013","unstructured":"Johnson RJ, Nakagawa T, Jalal D, S\u00e1nchez-Lozada LG, Kang DH, Ritz E. Uric acid and chronic kidney disease: which is chasing which? Nephrol Dial Transpl. 2013;28(9):2221\u20138. https:\/\/doi.org\/10.1093\/ndt\/gft029.","journal-title":"Nephrol Dial Transpl"},{"issue":"6","key":"26076_CR5","doi-asserted-by":"publisher","first-page":"403","DOI":"10.2188\/jea.10.403","volume":"10","author":"M Tomita","year":"2000","unstructured":"Tomita M, Mizuno S, Yamanaka H, Hosoda Y, Sakuma K, Matuoka Y, Odaka M, Yamaguchi M, Yosida H, Morisawa H, et al. Does hyperuricemia affect mortality? A prospective cohort study of Japanese male workers. J Epidemiol. 2000;10(6):403\u20139. https:\/\/doi.org\/10.2188\/jea.10.403.","journal-title":"J Epidemiol"},{"issue":"17","key":"26076_CR6","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.2169\/internalmedicine.46.0045","volume":"46","author":"M Hikita","year":"2007","unstructured":"Hikita M, Ohno I, Mori Y, Ichida K, Yokose T, Hosoya T. Relationship between hyperuricemia and body fat distribution. Intern Med. 2007;46(17):1353\u20138. https:\/\/doi.org\/10.2169\/internalmedicine.46.0045.","journal-title":"Intern Med"},{"issue":"4","key":"26076_CR7","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/s0272-6386(03)00020-9","volume":"41","author":"SJ Pinto-Sietsma","year":"2003","unstructured":"Pinto-Sietsma SJ, Navis G, Janssen WM, de Zeeuw D, Gans RO, de Jong PE. A central body fat distribution is related to renal function impairment, even in lean subjects. Am J Kidney Dis. 2003;41(4):733\u201341. https:\/\/doi.org\/10.1016\/s0272-6386(03)00020-9.","journal-title":"Am J Kidney Dis"},{"issue":"11","key":"26076_CR8","doi-asserted-by":"publisher","first-page":"3550","DOI":"10.1093\/ndt\/gfq634","volume":"26","author":"SR Kim","year":"2011","unstructured":"Kim SR, Yoo JH, Song HC, Lee SS, Yoo SJ, Kim YD, Lim YS, Kim HW, Yang CW, Kim YS, et al. Relationship of visceral and subcutaneous adiposity with renal function in people with type 2 diabetes mellitus. Nephrol Dial Transpl. 2011;26(11):3550\u20135. https:\/\/doi.org\/10.1093\/ndt\/gfq634.","journal-title":"Nephrol Dial Transpl"},{"issue":"1","key":"26076_CR9","doi-asserted-by":"publisher","first-page":"16753","DOI":"10.1038\/s41598-018-35073-4","volume":"8","author":"Y Park","year":"2018","unstructured":"Park Y, Kim NH, Kwon TY, Kim SG. A novel adiposity index as an integrated predictor of cardiometabolic disease morbidity and mortality. Sci Rep. 2018;8(1):16753. https:\/\/doi.org\/10.1038\/s41598-018-35073-4.","journal-title":"Sci Rep"},{"issue":"17","key":"26076_CR10","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1056\/NEJMra0800885","volume":"359","author":"DI Feig","year":"2008","unstructured":"Feig DI, Kang DH, Johnson RJ. Uric acid and cardiovascular risk. N Engl J Med. 2008;359(17):1811\u201321. https:\/\/doi.org\/10.1056\/NEJMra0800885.","journal-title":"N Engl J Med"},{"key":"26076_CR11","unstructured":"George C, Leslie SW, Minter DA. Hyperuricemia. [Updated 2023 Oct 14]. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2023 Jan\u2013. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK459218\/."},{"issue":"1","key":"26076_CR12","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/s41392-024-01916-y","volume":"9","author":"L Du","year":"2024","unstructured":"Du L, Zong Y, Li H, Wang Q, Xie L, Yang B, Pang Y, Zhang C, Zhong Z, Gao J. Hyperuricemia and its related diseases: mechanisms and advances in therapy. Signal Transduct Target Ther. 2024;9(1):212. https:\/\/doi.org\/10.1038\/s41392-024-01916-y.","journal-title":"Signal Transduct Target Ther"},{"issue":"4s","key":"26076_CR13","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.kint.2021.05.021","volume":"100","author":"KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases","year":"2021","unstructured":"KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases. Kidney Int. 2021;100(4s):S1\u2013276. https:\/\/doi.org\/10.1016\/j.kint.2021.05.021.","journal-title":"Kidney Int"},{"issue":"9","key":"26076_CR14","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604\u201312. https:\/\/doi.org\/10.7326\/0003-4819-150-9-200905050-00006.","journal-title":"Ann Intern Med"},{"issue":"6","key":"26076_CR15","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1093\/ndt\/gfx230","volume":"33","author":"RE Olivo","year":"2018","unstructured":"Olivo RE, Davenport CA, Diamantidis CJ, Bhavsar NA, Tyson CC, Hall R, Bidulescu A, Young B, Mwasongwe SE, Pendergast J, et al. Obesity and synergistic risk factors for chronic kidney disease in African American adults: the Jackson heart study. Nephrol Dial Transpl. 2018;33(6):992\u20131001. https:\/\/doi.org\/10.1093\/ndt\/gfx230.","journal-title":"Nephrol Dial Transpl"},{"issue":"3","key":"26076_CR16","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1159\/000368498","volume":"40","author":"SH Kang","year":"2015","unstructured":"Kang SH, Cho KH, Park JW, Yoon KW, Do JY. Association of visceral fat area with chronic kidney disease and metabolic syndrome risk in the general population: analysis using multi-frequency bioimpedance. Kidney Blood Press Res. 2015;40(3):223\u201330. https:\/\/doi.org\/10.1159\/000368498.","journal-title":"Kidney Blood Press Res"},{"issue":"2","key":"26076_CR17","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1053\/j.ajkd.2011.02.390","volume":"58","author":"H Kramer","year":"2011","unstructured":"Kramer H, Shoham D, McClure LA, Durazo-Arvizu R, Howard G, Judd S, Muntner P, Safford M, Warnock DG, McClellan W. Association of waist circumference and body mass index with all-cause mortality in CKD: the REGARDS (Reasons for geographic and Racial differences in Stroke) study. Am J Kidney Dis. 2011;58(2):177\u201385. https:\/\/doi.org\/10.1053\/j.ajkd.2011.02.390.","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"26076_CR18","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1007\/s12020-022-03030-x","volume":"76","author":"M Moltrer","year":"2022","unstructured":"Moltrer M, Pala L, Cosentino C, Mannucci E, Rotella CM, Cresci B. Body mass index (BMI), waist circumference (WC), waist-to-height ratio (WHtR) e waist body mass index (wBMI): which is better? Endocrine. 2022;76(3):578\u201383. https:\/\/doi.org\/10.1007\/s12020-022-03030-x.","journal-title":"Endocrine"},{"key":"26076_CR19","doi-asserted-by":"publisher","first-page":"941926","DOI":"10.3389\/fnut.2022.941926","volume":"9","author":"Z Qin","year":"2022","unstructured":"Qin Z, Chang K, Yang Q, Yu Q, Liao R, Su B. The association between weight-adjusted-waist index and increased urinary albumin excretion in adults: A population-based study. Front Nutr. 2022;9:941926. https:\/\/doi.org\/10.3389\/fnut.2022.941926.","journal-title":"Front Nutr"},{"issue":"3","key":"26076_CR20","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1093\/ageing\/afaa208","volume":"50","author":"NH Kim","year":"2021","unstructured":"Kim NH, Park Y, Kim NH, Kim SG. Weight-adjusted waist index reflects fat and muscle mass in the opposite direction in older adults. Age Ageing. 2021;50(3):780\u20136. https:\/\/doi.org\/10.1093\/ageing\/afaa208.","journal-title":"Age Ageing"},{"key":"26076_CR21","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3389\/fcvm.2020.00022","volume":"7","author":"A Chait","year":"2020","unstructured":"Chait A, den Hartigh LJ. Adipose tissue Distribution, inflammation and its metabolic Consequences, including diabetes and cardiovascular disease. Front Cardiovasc Med. 2020;7:22. https:\/\/doi.org\/10.3389\/fcvm.2020.00022.","journal-title":"Front Cardiovasc Med"},{"issue":"9","key":"26076_CR22","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/s41574-019-0230-6","volume":"15","author":"L Scheja","year":"2019","unstructured":"Scheja L, Heeren J. The endocrine function of adipose tissues in health and cardiometabolic disease. Nat Rev Endocrinol. 2019;15(9):507\u201324. https:\/\/doi.org\/10.1038\/s41574-019-0230-6.","journal-title":"Nat Rev Endocrinol"},{"issue":"2","key":"26076_CR23","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/nrneph.2017.157","volume":"14","author":"Q Zhu","year":"2018","unstructured":"Zhu Q, Scherer PE. Immunologic and endocrine functions of adipose tissue: implications for kidney disease. Nat Rev Nephrol. 2018;14(2):105\u201320. https:\/\/doi.org\/10.1038\/nrneph.2017.157.","journal-title":"Nat Rev Nephrol"},{"issue":"2","key":"26076_CR24","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/sj.ki.5000050","volume":"69","author":"H Tanaka","year":"2006","unstructured":"Tanaka H, Shiohira Y, Uezu Y, Higa A, Iseki K. Metabolic syndrome and chronic kidney disease in Okinawa, Japan. Kidney Int. 2006;69(2):369\u201374. https:\/\/doi.org\/10.1038\/sj.ki.5000050.","journal-title":"Kidney Int"},{"issue":"4","key":"26076_CR25","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/s41580-018-0093-z","volume":"20","author":"AL Ghaben","year":"2019","unstructured":"Ghaben AL, Scherer PE. Adipogenesis and metabolic health. Nat Rev Mol Cell Biol. 2019;20(4):242\u201358. https:\/\/doi.org\/10.1038\/s41580-018-0093-z.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"26076_CR26","doi-asserted-by":"publisher","unstructured":"Xu W, Zhu Y, Wang S, Liu J, Li H. From adipose to ailing kidneys: the role of lipid metabolism in Obesity-Related chronic kidney disease. Antioxid (Basel). 2024;13(12). https:\/\/doi.org\/10.3390\/antiox13121540.","DOI":"10.3390\/antiox13121540"},{"issue":"7","key":"26076_CR27","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/j.cmet.2021.06.006","volume":"33","author":"CD Green","year":"2021","unstructured":"Green CD, Maceyka M, Cowart LA, Spiegel S. Sphingolipids in metabolic disease: the good, the bad, and the unknown. Cell Metab. 2021;33(7):1293\u2013306. https:\/\/doi.org\/10.1016\/j.cmet.2021.06.006.","journal-title":"Cell Metab"},{"issue":"3","key":"26076_CR28","doi-asserted-by":"publisher","first-page":"F431","DOI":"10.1152\/ajprenal.00193.2024","volume":"328","author":"N Li","year":"2025","unstructured":"Li N, Li G. Sphingolipid signaling in kidney diseases. Am J Physiol Ren Physiol. 2025;328(3):F431\u201343. https:\/\/doi.org\/10.1152\/ajprenal.00193.2024.","journal-title":"Am J Physiol Ren Physiol"},{"issue":"3","key":"26076_CR29","doi-asserted-by":"publisher","first-page":"103388","DOI":"10.1016\/j.jpet.2025.103388","volume":"392","author":"L Xing","year":"2025","unstructured":"Xing L, Wu S, Shi Y, Wei L, Yue F, Lam SM, Shui G, Russell R, Zhang D. Metformin alleviates sphingolipids dysregulation and improves obesity-related kidney disease in high-fat diet rats. J Pharmacol Exp Ther. 2025;392(3):103388. https:\/\/doi.org\/10.1016\/j.jpet.2025.103388.","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"26076_CR30","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1186\/s13075-023-03204-6","volume":"25","author":"A Kvasni\u010dka","year":"2023","unstructured":"Kvasni\u010dka A, Friedeck\u00fd D, Brumarov\u00e1 R, Pavl\u00edkov\u00e1 M, Pavelcov\u00e1 K, Ma\u0161\u00ednov\u00e1 J, Has\u00edkov\u00e1 L, Z\u00e1vada J, Pavelka K, Je\u0161ina P, et al. Alterations in lipidome profiles distinguish early-onset hyperuricemia, gout, and the effect of urate-lowering treatment. Arthritis Res Ther. 2023;25(1):234. https:\/\/doi.org\/10.1186\/s13075-023-03204-6.","journal-title":"Arthritis Res Ther"},{"issue":"10","key":"26076_CR31","doi-asserted-by":"publisher","first-page":"13474","DOI":"10.1096\/fj.202000950R","volume":"34","author":"N Liu","year":"2020","unstructured":"Liu N, Sun Q, Xu H, Yu X, Chen W, Wei H, Jiang J, Xu Y, Lu W. Hyperuricemia induces lipid disturbances mediated by LPCAT3 upregulation in the liver. Faseb J. 2020;34(10):13474\u201393. https:\/\/doi.org\/10.1096\/fj.202000950R.","journal-title":"Faseb J"},{"issue":"5","key":"26076_CR32","doi-asserted-by":"publisher","first-page":"365","DOI":"10.14348\/molcells.2014.0074","volume":"37","author":"JY Huh","year":"2014","unstructured":"Huh JY, Park YJ, Ham M, Kim JB. Crosstalk between adipocytes and immune cells in adipose tissue inflammation and metabolic dysregulation in obesity. Mol Cells. 2014;37(5):365\u201371. https:\/\/doi.org\/10.14348\/molcells.2014.0074.","journal-title":"Mol Cells"},{"issue":"1","key":"26076_CR33","doi-asserted-by":"publisher","first-page":"92","DOI":"10.3109\/0886022x.2013.830975","volume":"36","author":"Y Yu","year":"2014","unstructured":"Yu Y, Bao BJ, Fan YP, Shi L, Li SQ. Changes of adiponectin and its receptors in rats following chronic renal failure. Ren Fail. 2014;36(1):92\u20137. https:\/\/doi.org\/10.3109\/0886022x.2013.830975.","journal-title":"Ren Fail"},{"issue":"0 3","key":"26076_CR34","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1111\/dom.12154","volume":"15","author":"AW Ferrante","year":"2013","unstructured":"Ferrante AW. Jr. The immune cells in adipose tissue. Diabetes Obes Metab. 2013;15(0 3):34\u20138. https:\/\/doi.org\/10.1111\/dom.12154.","journal-title":"Diabetes Obes Metab"},{"issue":"8","key":"26076_CR35","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nrneph.2016.75","volume":"12","author":"VD D\u2019Agati","year":"2016","unstructured":"D\u2019Agati VD, Chagnac A, de Vries AP, Levi M, Porrini E, Herman-Edelstein M, Praga M. Obesity-related glomerulopathy: clinical and pathologic characteristics and pathogenesis. Nat Rev Nephrol. 2016;12(8):453\u201371. https:\/\/doi.org\/10.1038\/nrneph.2016.75.","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"26076_CR36","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1152\/physrev.00033.2011","volume":"93","author":"A Tchernof","year":"2013","unstructured":"Tchernof A, Despr\u00e9s JP. Pathophysiology of human visceral obesity: an update. Physiol Rev. 2013;93(1):359\u2013404. https:\/\/doi.org\/10.1152\/physrev.00033.2011.","journal-title":"Physiol Rev"},{"issue":"5","key":"26076_CR37","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.2337\/dc19-2095","volume":"43","author":"YH Kim","year":"2020","unstructured":"Kim YH, Kang JG, Lee SJ, Han KD, Ihm SH, Cho KH, Park YG Underweight Increases the Risk of End-Stage Renal Diseases for Type 2 Diabetes in Korean Population: Data From the National Health Insurance Service Health Checkups 2009-2017. Diabetes Care. 2020;43(5):1118\u201325. https:\/\/doi.org\/10.2337\/dc19-2095.","journal-title":"Diabetes Care"},{"issue":"8","key":"26076_CR38","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1007\/s12603-018-1042-4","volume":"22","author":"WJ Lee","year":"2018","unstructured":"Lee WJ, Peng LN, Loh CH, Chen LK. Effect of body Weight, waist circumference and their changes on mortality: a 10-Year Population-based study. J Nutr Health Aging. 2018;22(8):959\u201364. https:\/\/doi.org\/10.1007\/s12603-018-1042-4.","journal-title":"J Nutr Health Aging"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-025-26076-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-26076-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-26076-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T15:52:14Z","timestamp":1781625134000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12889-025-26076-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,28]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["26076"],"URL":"https:\/\/doi.org\/10.1186\/s12889-025-26076-8","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,28]]},"assertion":[{"value":"8 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All NHANES protocols are approved by the NCHS Research Ethics Review Board, and all participants signed informed consent forms to participate in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"396"}}